Socioeconomic status and determinants of hemostatic function in healthy women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 485-492

  Wamala, Sarah P ^a   Murray, Mittleman A ^b   Horsten, Myriam ^a   Eriksson, Margita ^c   Schenck Gustafsson, Karin ^c   Hamsten, Anders ^c   Silveira, Angela ^c   Orth Gomér, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hemostatic function; Life style; Psychosocial stress; Socioeconomic status; Women

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; SOCIAL PROBLEM; SOCIOECONOMICS; SWEDEN;

EID: 0033013635     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.485     Document Type: Article

References (62)

1. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Hemostatic function in ischemic heart disease: principal results of the Northwick Park Study. Lancet. 1986;2:533-537.
2. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
3. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 1987;258: 1183-1186.
4. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
5. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol. 1990;43:933-939.
6. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARJC) Study. Circulation. 1997;96:1102-1108.
7. Hamsten A, de Faire U, Waldius G, Dahlen G, Szamosi A, Landou C, Blombäck M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
8. Haines AP, Howarth D, North WR, Goldenberg E, Stirling Y, Meade TW. Hemostatic variables and the outcome of myocardial infarction. Thromb Haemost. 1983;50:800-803.
9. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351-355.
10. Yarnell JWG, Sweetnam PM, Elwood PC, Eastham R, Gilmor RA, O'Brien JR. Hemostatic factors and ischemic heart disease: The Caerphilly study. Br Heart J. 1985;53:483-487.
11. Cortellaro M, Broschetti C, Cofrancesco E, Zanusi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, della Volpe A, Polli E, and the PLAT Study Group. The PLAT study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results. Arterioscler Thromb. 1992; 12:1063-1070.
12. Thompson SG, Kienast J, Pyke S, Haverkate F, van de Loo J. Hemostatic factors and the risk for myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
13. Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CR, Barbanel JC. Relation between extent of coronary artery disease and blood viscosity. BMJ. 1980;1:673-674.
14. Handa K, Kono S, Saku K, Sasaki J, Kawano T, Hiroki T, Arkawa K. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis. 1989;77:209-213.
15. Smith EB, Staples EM. Hemostatic factors in human aortic intima. Lancet. 1981;1:1171-1174.
16. Grotta JC, Yatsu FM, Pettigrew LC, Rhoades H, Bratina P, Vital D, Alam R, Earls R, Picone C. Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology. 1989;39:1325-1331.
17. Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. Association of coagulation and inhibitors with carotid artery atherosclerosis: early results of the ARIC study. Ann Epidemiol. 1992;2:471-480.
18. Miller GJ. Environmental influences on hemostasis and thrombosis: diet and smoking. Ann Epidemiol. 1992;2:387-391.
19. Winldeby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82: 816-820.
20. Wilson T, Kaplan GA, Kauhanen J, Cohen R, Wu M, Salonen R, Salonen JT. Association between plasma fibrinogen concentration and five socioeconomic indices in Kuopio Ischemic Heart Disease Risk Factor Study. Am J Epidemiol. 1993;137:292-300.
21. Moller L, Kristensen TS, Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb. 1991;11:344-350.
22. Myllykangas M, Pekkanen J, Rasi V, Haukkala A, Vantera E, Salomaa V. Hemostatic and other cardiovascular factors and socioeconomic status among middle aged Finnish men and women. Int J Epidemiol. 1995;24: 1110-1116.
23. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991;91:191-205.
24. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle aged adults. Ann Epidemiol. 1992;2:481-494.
25. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb. 1994;14:193-198.
26. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis. 1992;94:43-50.
27. Hamsten A, Eriksson P, Karpe F, Silveira A. Relationship of thrombosis and fibrinolysis to atherosclerosis. Curr Opin Lipidol. 1994;5:382-389.
28. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: insights from the Framingham study. Am Heart J. 1987;113:1006-1010
29. Rosengren A, Wilhelmsen L, Welin L, Tsipogiami A, Teger-Nilsson AC, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ. 1990;300:634-638.
30. Balleisen L, Assmann G, Bailey J, Epping PH, Schule H, Van de Loo J. Epidemiological study on factor VII, VIII and fibrinogen in an industrial population, II: baseline data on the relation to blood pressure, blood glucose, uric acid and lipid fractions. Thromb Haemost. 1985;54: 721-723.
31. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP. Association of fibrinogen and coagulation factors VII and VII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Am J Epidemiol. 1996;143:665-676.
32. Brunner E, Smith GD, Marmot MG, Canner R, Beksinska M, O'Brien J. Childhood social circumstances and psychological and behavioral factors as determinants of plasma fibrinogen. Lancet. 1996;347: 1008-1013.
33. Davis MC, Mathews KA, Meilahn EN, Kiss JE. Are job characteristics related to fibrinogen levels in middle-aged women? Health Psychol. 1993;4:310-318.
34. Mattiasson I, Lindgarde F. The effect of psychosocial stress and risk factors for ischemic heart disease on the plasma fibrinogen concentration. J Intern Med. 1993;234:45-51.
35. Orth-Gomér K, Mittleman M, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belkic K, Kirkeeide R, Svane B, Rydén L. Lipoprotein(a) as determinant of coronary heart disease in young women. Circulation. 1997;95:329-334.
36. Romelsjö A, Hasin D, Hilton M, Boström G, Diderichsen F, Haglund B, Hallqvist J, Karlsson G, Svanström L. The relationship between stressful working conditions and high alcohol consumption and severe alcohol problems in an urban general population. Br J Addict. 1992;87: 1173-1183.
37. Vermylen C, de Vreker RA, Verstraete M. A rapid enzymatic method for assay fibrinogen: fibrin polymerization time (FPT test). Clin Chim Acta. 1963;8:418-424.
38. Amiral J, Adalbert B, Adam M. Application enzyme immunoassay to coagulation testing. Clin Chem. 1984;30:1512-1516.
39. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor Vila in hemophilia A and B patients. Blood. 1992;80:25-28.
40. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantification of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81: 734-744.
41. Silveira A, Green F, Karper F, Blombäck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost. 1994;72:734-739.
42. Wiman B, Chmielewska J, Ranby M. Inactivation of tissue plasminogen activator in plasma: demonstration of a complex with a new rapid inhibitor. J Biol Chem. 1984;259:3644-3657.
43. Undén A-L, Orth-Gomér K. Development of a social support instrument for use in population surveys. Soc Sci Med. 1989;29:1387-1392.
44. Karasek R, Baker D, Marxer F, Ahlbom A, Theorell T. Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health. 1981;71:694-705.
45. Willet WC, Sampson L. Stampfer J, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of semiquantitative food frequency questionnaire. Am J Epidemiol. 1995;122:51-65.
46. Wamala SP, Wolk A, Orth-Gomér K. Determinants of obesity in relation to socioeconomic status in middle aged Swedish women. Prev Med. 1997;26:734-744.
47. Myrhed M. Alcohol consumption in relation to factors associated with ischemic heart disease: a cotwin control study. Acta Med Scand. 1974; suppl:567.
48. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoprotein A-1 and B in serum. Scand J Clin Lab Invest. 1987;47:739-744.
49. Harju L, Munter M. A quantitative immunonephelometric determination of C-reactive protein in serum. Kuopio, Finland: XXI Nordic Congress in Clinical Chemistry. 1988.
50. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24-27.
51. Jungner I, Walldius G, Holme I, Steiner E. Apolipoprotein B and A-1 in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females. Int J Clin Lab Res. 1992;21:247-255.
52. Study Group of the European Atherosclerotic Society. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerotic Society. Eur Heart J. 1987;8:77-78.
53. Brindley DN, McCann BS, Niaura R, Stooney CM, Suarez EC. Stress and lipoprotein metabolism: modulators and mechanisms. Metabolism 1993; 42(suppl 1):3-15.
54. Wamala SP, Wolk A, Schenck-Gustafsson K, Orth-Gomér K. Socioeconomic status and lipid profile in healthy middle-aged women in Sweden. J Epidemiol Community Health. 1997;51:400-407.
55. Brozovic M. Physiology mechanisms in coagulation and fibrinolysis. Br Med Bull. 1977;33:23123-23128.
56. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a metaanalysis and review of the literature. Ann Intern Med. 1993;118:956-963.
57. Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharmacol Sci. 1990;11:444-451.
58. Wolinsky HA. A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res. 1980;47:301-311.
59. Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol. 1991;14:731-736.
60. Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med. 1995;332:677-679.
61. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
62. Dormandy J, Ernst E, Matrai A, Flute PT. Hemorheological changes following acute MI. Am Heart J. 1982;104:1364-1367.